April 4, 2019
Frequency Therapeutics Announces Appointment of Glenn Dubin to Board of Directors
WOBURN, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BOD?src=hash" target="_blank"gt;#BODlt;/agt;–Frequency Therapeutics, a clinical-stage biotechnology company creating a new class of drugs based on small molecule…